2020 Q1 Form 10-Q Financial Statement

#000143774920010112 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $53.08M $48.50M $65.51M
YoY Change 9.45% -13.0% -12.95%
Cost Of Revenue $36.70M $45.20M $50.50M
YoY Change -18.81% 272.35% -26.28%
Gross Profit $16.40M $3.262M $14.97M
YoY Change 402.73% -91.3% 119.88%
Gross Profit Margin 30.89% 6.73% 22.85%
Selling, General & Admin $1.600M $1.300M $1.500M
YoY Change 23.08% -27.78% -16.67%
% of Gross Profit 9.76% 39.85% 10.02%
Research & Development $835.0K $706.0K $700.0K
YoY Change 18.27% -40.27% -36.36%
% of Gross Profit 5.09% 21.64% 4.68%
Depreciation & Amortization $3.004M $2.725M $2.730M
YoY Change 10.24% -1.12% -5.21%
% of Gross Profit 18.32% 83.54% 18.24%
Operating Expenses $2.420M $2.051M $2.200M
YoY Change 17.99% -30.24% -24.14%
Operating Profit $13.98M $1.211M $12.77M
YoY Change 1054.34% -96.5% 226.77%
Interest Expense $56.00K $43.00K -$6.300M
YoY Change 30.23% 0.0% -431.58%
% of Operating Profit 0.4% 3.55% -49.35%
Other Income/Expense, Net -$8.148M $5.246M $0.00
YoY Change -255.32% -316.78% -100.0%
Pretax Income $5.831M $6.457M $6.500M
YoY Change -9.69% -79.91% 14.04%
Income Tax -$13.21M $958.0K $4.700M
% Of Pretax Income -226.58% 14.84% 72.31%
Net Earnings $19.04M $5.499M $1.836M
YoY Change 246.3% -84.65% -88.49%
Net Earnings / Revenue 35.87% 11.34% 2.8%
Basic Earnings Per Share $0.44 $0.13 $0.04
Diluted Earnings Per Share $0.44 $0.13 $0.04
COMMON SHARES
Basic Shares Outstanding 43.74M 43.74M
Diluted Shares Outstanding 43.74M 43.75M

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $307.7M $290.5M $294.9M
YoY Change 5.92% 29.08% 32.83%
Cash & Equivalents $248.1M $206.0M $215.0M
Short-Term Investments $59.60M $84.50M $79.89M
Other Short-Term Assets $1.610M $930.0K $1.399M
YoY Change 73.12% -25.42% 261.5%
Inventory $41.45M $53.33M $39.30M
Prepaid Expenses $1.761M $1.383M $1.767M
Receivables $128.1M $17.61M $16.29M
Other Receivables $21.60M $5.600M $6.900M
Total Short-Term Assets $502.7M $369.5M $362.3M
YoY Change 36.04% 1.21% 16.75%
LONG-TERM ASSETS
Property, Plant & Equipment $96.95M $102.8M $103.6M
YoY Change -5.74% -4.23% -5.61%
Goodwill
YoY Change
Intangibles $1.408M $1.408M $1.408M
YoY Change 0.0% 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets $5.813M $5.864M $3.842M
YoY Change -0.87% 48.34% -1.03%
Total Long-Term Assets $104.2M $110.1M $108.8M
YoY Change -5.41% -2.46% -5.54%
TOTAL ASSETS
Total Short-Term Assets $502.7M $369.5M $362.3M
Total Long-Term Assets $104.2M $110.1M $108.8M
Total Assets $606.9M $479.7M $471.2M
YoY Change 26.52% 0.34% 10.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.46M $23.48M $19.98M
YoY Change 170.22% -32.98% 8.62%
Accrued Expenses $6.602M $4.130M $2.742M
YoY Change 59.85% -44.7% 11.1%
Deferred Revenue $3.886M $20.42M $4.374M
YoY Change -80.97% 4.75% -79.18%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $213.7M $41.18M $39.49M
YoY Change 418.92% -29.98% 11.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.329M $5.723M $4.241M
YoY Change -59.3% 410.07% 280.36%
Total Long-Term Liabilities $38.55M $43.70M $42.59M
YoY Change -11.78% 18.35% 10.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $213.7M $41.18M $39.49M
Total Long-Term Liabilities $38.55M $43.70M $42.59M
Total Liabilities $252.2M $84.88M $82.08M
YoY Change 197.19% -11.35% 10.96%
SHAREHOLDERS EQUITY
Retained Earnings $72.43M $112.4M $106.9M
YoY Change -35.59% 12.32% 74.77%
Common Stock $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $354.6M $394.8M $389.1M
YoY Change
Total Liabilities & Shareholders Equity $606.9M $479.7M $471.2M
YoY Change 26.52% 0.34% 10.71%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income $19.04M $5.499M $1.836M
YoY Change 246.3% -84.65% -88.49%
Depreciation, Depletion And Amortization $3.004M $2.725M $2.730M
YoY Change 10.24% -1.12% -5.21%
Cash From Operating Activities $4.034M -$3.289M $6.440M
YoY Change -222.65% -185.65% 121.31%
INVESTING ACTIVITIES
Capital Expenditures $1.608M $2.246M -$1.790M
YoY Change -28.41% 424.77% 84.54%
Acquisitions
YoY Change
Other Investing Activities $5.450M -$790.0K $13.59M
YoY Change -789.87% -103.95% 566.18%
Cash From Investing Activities $3.838M -$3.038M $11.81M
YoY Change -226.33% -115.54% 1003.74%
FINANCING ACTIVITIES
Cash Dividend Paid $2.624M $2.624M
YoY Change 0.0% 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$3.101M -2.624M -2.620M
YoY Change 18.18% 0.0% 1.16%
NET CHANGE
Cash From Operating Activities $4.034M -3.289M 6.440M
Cash From Investing Activities $3.838M -3.038M 11.81M
Cash From Financing Activities -$3.101M -2.624M -2.620M
Net Change In Cash $4.771M -8.951M 15.63M
YoY Change -153.3% -143.1% 1024.46%
FREE CASH FLOW
Cash From Operating Activities $4.034M -$3.289M $6.440M
Capital Expenditures $1.608M $2.246M -$1.790M
Free Cash Flow $2.426M -$5.535M $8.230M
YoY Change -143.83% -262.22% 112.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001337298
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43743243
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
FUTUREFUEL CORP.
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Trading Symbol
TradingSymbol
ff
CY2020Q1 ff Accounts Payable Blenders Tax Credit Payables
AccountsPayableBlendersTaxCreditPayables
41440000
CY2019Q4 ff Accounts Payable Blenders Tax Credit Payables
AccountsPayableBlendersTaxCreditPayables
39423000
CY2020Q1 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
108599000
CY2019Q4 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
97294000
CY2020Q1 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2019Q4 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
64000
CY2020Q1 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
6602000
CY2019Q4 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
4410000
CY2020Q1 ff Adjustments To Additional Paid In Capital Sharebased Payment Arrangement Increase Decrease For Cost Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedPaymentArrangementIncreaseDecreaseForCostRecognition
49000
CY2020Q1 ff Btc Rebate
BTCRebate
2017000
CY2019Q1 ff Btc Rebate
BTCRebate
CY2020Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
1874000
CY2019Q1 ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
286000
CY2020Q1 ff Contract With Customer Aggregate Liability Current
ContractWithCustomerAggregateLiabilityCurrent
4093000
CY2019Q4 ff Contract With Customer Aggregate Liability Current
ContractWithCustomerAggregateLiabilityCurrent
5237000
CY2020Q1 ff Contract With Customer Aggregate Liability Noncurrent
ContractWithCustomerAggregateLiabilityNoncurrent
23360000
CY2019Q4 ff Contract With Customer Aggregate Liability Noncurrent
ContractWithCustomerAggregateLiabilityNoncurrent
21291000
CY2020Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
-64000
CY2019Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2020Q1 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000
CY2019Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
63456000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61299000
CY2020Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
440000
CY2019Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1255000
CY2020Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
18974000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
11902000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
128055000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110264000
CY2020Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
427000
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
4602000
CY2020Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2477000
CY2019Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1226000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6602000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4410000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
296000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
282215000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
282166000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
33000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000
CY2020Q1 us-gaap Area Of Land
AreaOfLand
2200
CY2020Q1 us-gaap Assets
Assets
606878000
CY2019Q4 us-gaap Assets
Assets
586505000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
502711000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
480889000
CY2020Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
104167000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
105616000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
30000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
378000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
51000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5104000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5104000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
5104000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
5083000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5083000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
248102000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243331000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214972000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
206021000
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4771000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8951000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5479000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
210000
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
56000
CY2019Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43743243
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43743243
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43743243
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43743243
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
4000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18730000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5701000
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
515000
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1067000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3886000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5030000
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19276000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
17151000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1327000
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1351000
CY2020Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
3625000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
151000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-22000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-415000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12859000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12965000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3004000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2725000
CY2020Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
6857000
CY2019Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1476000
CY2020Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt; min-width: 700px;" cellspacing="0pt" cellpadding="0pt"> <tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">16</div></div><div style="display: inline; font-weight: bold;">)</div>&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;RECENTLY ISSUED ACCOUNTING STA</div><div style="display: inline; font-weight: bold;">NDARDS</div><div style="display: inline; font-weight: bold;">&nbsp;</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 15pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:34.2pt;margin-right:7.2pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Recently Adopted &nbsp;Accounting Standards&nbsp; </div></div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">In the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of <div style="display: inline; font-style: italic; font: inherit;">2020,</div> the Company adopted ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13,</div> "Financial Instruments - Credit Losses (Topic <div style="display: inline; font-style: italic; font: inherit;">326</div>): Measurement of Credit Losses on Financial Instruments" and the associated ASUs (collectively &#x201c;Topic <div style="display: inline; font-style: italic; font: inherit;">326&#x201d;</div>). The amendments replace the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates on a modified retrospective approach. The Company recorded a reduction to opening retained earnings of <div style="display: inline; font-style: italic; font: inherit;">$12</div> and an allowance for bad debt of <div style="display: inline; font-style: italic; font: inherit;">$12</div> on our consolidated financial statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Recently Issued Accounting Standards <div style="display: inline; font-style: italic; font: inherit;">Not</div> Adopted</div></div> &nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">In <div style="display: inline; font-style: italic; font: inherit;"> December 2019, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font: inherit;">2019</div>-<div style="display: inline; font-style: italic; font: inherit;">12,</div> "Income Taxes (Topic <div style="display: inline; font-style: italic; font: inherit;">740</div>): Simplifying the Accounting for Income Taxes." The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic <div style="display: inline; font-style: italic; font: inherit;">740,</div> "Income Taxes" and improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2020. </div>Early adoption is permitted, with the amendments to be applied on a retrospective, modified retrospective or prospective basis, depending on the specific amendment. The Company is currently evaluating the impact of adopting this guidance.&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Other</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">ASU <div style="display: inline; font-style: italic; font: inherit;">2020</div>-<div style="display: inline; font-style: italic; font: inherit;">04,</div>&nbsp;<div style="display: inline; font-style: italic;">Reference Rate Reform </div>(Topic <div style="display: inline; font-style: italic; font: inherit;">848</div>):<div style="display: inline; font-style: italic;"> Facilitation of the Effects of Reference Rate Reform on Financial&nbsp;Reporting</div>.&nbsp; Effective <div style="display: inline; font-style: italic; font: inherit;"> March 12, 2020, </div>the guidance in the update is in response to concerns about structural risks of interbank offered rates (IBORs), and, particularly, the risk of cessation of the London Interbank Offered Rate (LIBOR), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. This&nbsp;guidance will ease the accounting burden associated with transitioning away from&nbsp;reference rates that are expected to be discontinued within our credit facility as described in Note <div style="display: inline; font-style: italic; font: inherit;">10.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt 0pt 34pt; text-align: left;">.</div></div>
CY2020Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2020-04-17
CY2020Q1 us-gaap Dividends
Dividends
131230000
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
139104000
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10498000
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
131230
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
131230000
CY2019Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-2.266
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.148
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3404000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2534000
CY2020Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-489000
CY2019Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-80000
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-9570000
CY2019Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
3008000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
CY2020Q1 us-gaap Gross Profit
GrossProfit
16399000
CY2019Q1 us-gaap Gross Profit
GrossProfit
3262000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5831000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6457000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13212000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
958000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
453000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
21649000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8062000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-815000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-619000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2360000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3634000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17803000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1320000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-4175000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1720000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2192000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
807000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
925000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
31000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
13587000
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1340000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3878000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13926000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-78000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-17000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-120000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-36000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-171000
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-384000
CY2020Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-1876000
CY2019Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-590000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5731
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2020Q1 us-gaap Interest Expense
InterestExpense
56000
CY2019Q1 us-gaap Interest Expense
InterestExpense
43000
CY2020Q1 us-gaap Interest Expense Other
InterestExpenseOther
19000
CY2019Q1 us-gaap Interest Expense Other
InterestExpenseOther
7000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22807000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22564000
CY2020Q1 us-gaap Inventory Gross
InventoryGross
48012000
CY2019Q4 us-gaap Inventory Gross
InventoryGross
45453000
CY2020Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
6561000
CY2019Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
7880000
CY2020Q1 us-gaap Inventory Net
InventoryNet
41451000
CY2019Q4 us-gaap Inventory Net
InventoryNet
37573000
CY2020Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
22637000
CY2019Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
20121000
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2568000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2768000
CY2020Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1967000
CY2019Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2362000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
855000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
715000
CY2020Q1 us-gaap Liabilities
Liabilities
252243000
CY2019Q4 us-gaap Liabilities
Liabilities
119407000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
606878000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
586505000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
213695000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82763000
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38548000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
36644000
CY2020Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
59644000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
73620000
CY2020Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-10059000
CY2019Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
2927000
CY2020Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">1</div></div><div style="display: inline; font-weight: bold;">)</div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NATURE OF OPERATIONS AND BASIS OF PRESENTATION</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 15pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Organization</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">FutureFuel Corp. (&#x201c;FutureFuel&#x201d; or &#x201c;the Company&#x201d;), through its wholly-owned subsidiary, FutureFuel Chemical Company (&#x201c;FutureFuel Chemical&#x201d;), owns and operates a chemical production facility located on approximately <div style="display: inline; font-style: italic; font: inherit;">2,200</div> acres of land <div style="display: inline; font-style: italic; font: inherit;">six</div> miles southeast of Batesville in north central Arkansas fronting the White River (the &#x201c;Batesville Plant&#x201d;). FutureFuel Chemical manufactures diversified chemical products, biobased products composed of biofuels, and biobased specialty chemical products. FutureFuel Chemical&#x2019;s operations are reported in <div style="display: inline; font-style: italic; font: inherit;">two</div> segments: chemicals and biofuels.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">The chemical segment manufactures a diversified portfolio of chemical products that are sold to <div style="display: inline; font-style: italic; font: inherit;">third</div> party customers. The majority of the revenues from the chemical segment are derived from the custom manufacturing of specialty chemicals for specific customers.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">The biofuels segment primarily produces and sells biodiesel. FutureFuel Chemical also sells petrodiesel in blends with the Company&#x2019;s biodiesel and, from time to time, with <div style="display: inline; font-style: italic; font: inherit;">no</div> biodiesel added. FutureFuel Chemical is a shipper of refined petroleum products on common carrier pipelines and buys and sells petroleum products to maintain an active shipper status on these pipelines.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Basis</div> <div style="display: inline; font-style: italic;">of</div> <div style="display: inline; font-style: italic;">Presentation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">The unaudited consolidated financial statements have been prepared by FutureFuel in accordance and consistent with the accounting policies stated in FutureFuel&#x2019;s <div style="display: inline; font-style: italic; font: inherit;">2019</div> audited consolidated financial statements and should be read in conjunction with the <div style="display: inline; font-style: italic; font: inherit;">2019</div> audited consolidated financial statements of FutureFuel.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">In the opinion of FutureFuel, all normal recurring adjustments necessary for a fair presentation have been included in the unaudited consolidated financial statements. The unaudited consolidated financial statements have been prepared in compliance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information and with instructions to Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q adopted by the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly the unaudited consolidated financial statements do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all the information and footnotes required by GAAP for complete financial statements, and do include amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The unaudited consolidated financial statements include assets, liabilities, revenues, and expenses of FutureFuel and its direct and indirect wholly owned subsidiaries; namely, FutureFuel Chemical Company; FFC Grain, L.L.C.; FutureFuel Warehouse Company, L.L.C.; and Legacy Regional Transport, L.L.C. Intercompany transactions and balances have been eliminated in consolidation.</div></div>
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3101000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2624000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3838000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3038000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4034000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3289000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
19043000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
5499000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8148000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5246000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
2420000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
2051000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13979000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1211000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
237000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
113000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1610000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1493000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5813000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5611000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-313000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
202000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-397000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
256000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-313000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
202000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-84000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
54000
CY2020Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
582000
CY2019Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
501000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2329000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2388000
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
477000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2624000
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2624000
CY2015Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1408000
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
964000
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9096000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1608000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2246000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1761000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1932000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4484000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7709000
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
96946000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98597000
CY2020Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
148000
CY2019Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
129000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
835000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
706000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
785000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
-3000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
-557000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
49000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72433000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
184632000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
354635000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
467098000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
389078000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
394779000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1091000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53082000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48501000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23162
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.17
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.83
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
432000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43743243
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43748974
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43743243
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43743243

Files In Submission

Name View Source Status
0001437749-20-010112-index-headers.html Edgar Link pending
0001437749-20-010112-index.html Edgar Link pending
0001437749-20-010112.txt Edgar Link pending
0001437749-20-010112-xbrl.zip Edgar Link pending
ex_181398.htm Edgar Link pending
ex_181399.htm Edgar Link pending
ex_184728.htm Edgar Link pending
ex_184750.htm Edgar Link pending
ex_184751.htm Edgar Link pending
ex_184757.htm Edgar Link pending
ff-20200331.xml Edgar Link completed
ff-20200331.xsd Edgar Link pending
ff-20200331_cal.xml Edgar Link unprocessable
ff-20200331_def.xml Edgar Link unprocessable
ff-20200331_lab.xml Edgar Link unprocessable
ff-20200331_pre.xml Edgar Link unprocessable
ff20200331_10q.htm Edgar Link pending
ff20200331_10qimg001.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending